These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 4818768)

  • 1. Studies on the mechanism of the dopamine-mediated inhibition of prolactin secretion.
    MacLeod RM; Lehmeyer JE
    Endocrinology; 1974 Apr; 94(4):1077-85. PubMed ID: 4818768
    [No Abstract]   [Full Text] [Related]  

  • 2. Action of dopamine receptor agonists and antagonists, and a serotonin antagonist on prolactin release from isolated rat pituitary cell columns [proceedings].
    Delitala G; Stubbs WA; Yeo T; Jones A; Thorner MO; Besser GM
    J Endocrinol; 1979 May; 81(2):121P. PubMed ID: 458305
    [No Abstract]   [Full Text] [Related]  

  • 3. Restoration of prolactin synthesis and release by the administration of monoaminergic blocking agents to pituitary tumor-bearing rats.
    MacLeod RM; Lehmeyer JE
    Cancer Res; 1974 Feb; 34(2):345-50. PubMed ID: 4810907
    [No Abstract]   [Full Text] [Related]  

  • 4. The biphasic regulation of prolactin secretion by dopamine agonist-antagonists.
    MacLeod RM; Lamberts SW
    Endocrinology; 1978 Jul; 103(1):200-3. PubMed ID: 744072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catecholamine inhibition of prolactin secretion by isolated rat adenohypophyses.
    Birge CA; Jacobs LS; Hammer CT; Daughaday WH
    Endocrinology; 1970 Jan; 86(1):120-30. PubMed ID: 5409444
    [No Abstract]   [Full Text] [Related]  

  • 6. Direct inhibition of pituitary LH secretion in rats by CB-154 (2-Br-alpha-ergocryptine).
    Seki M; Seki K; Yoshihara T; Watanabe N; Okumura T
    Endocrinology; 1974 Mar; 94(3):911-4. PubMed ID: 4591828
    [No Abstract]   [Full Text] [Related]  

  • 7. Total blockade of phasic pituitary prolactin release in rats: effect on serum LH and progesterone during the estrous cycle and pregnancy.
    Döhler KD; Wuttke W
    Endocrinology; 1974 Jun; 94(6):1595-600. PubMed ID: 4831125
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition by apomorphine of prolactin secretion in patients with elevated serum prolactin.
    Martin JB; Lal S; Tolis G; Friesen HG
    J Clin Endocrinol Metab; 1974 Jul; 39(1):180-2. PubMed ID: 4835131
    [No Abstract]   [Full Text] [Related]  

  • 9. Mammotropic effect of prolactin enhanced by thyroidectomy.
    Mittra I
    Nature; 1974 Apr; 248(448):525-6. PubMed ID: 4824351
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of 2-Br-alpha-ergocryptine on pituitary synthesis and release of prolactin and growth hormone in rats.
    Yanai R; Nagasawa H
    Horm Res; 1974 Jan; 5(1):1-5. PubMed ID: 4810405
    [No Abstract]   [Full Text] [Related]  

  • 11. DNA synthesis and the secretion of prolactin and growth hormone by the pituitary gland of the male rat: effects of diethylstilboestrol and 2-bromo-alpha-ergocryptine methanesluphonate.
    Davies C; Jacobi J; Lloyd HM; Meares JD
    J Endocrinol; 1974 Jun; 61(3):411-7. PubMed ID: 4366118
    [No Abstract]   [Full Text] [Related]  

  • 12. Direct inhibition by ergocornine of pituitary prolactin release.
    Lu KH; Koch Y; Meites J
    Endocrinology; 1971 Jul; 89(1):229-33. PubMed ID: 5089657
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of thyrotropin-releasing hormone and dopamine on the release of prolactin from the rat anterior pituitary in vitro.
    Hill-Samli M; MacLeod RM
    Endocrinology; 1974 Oct; 95(4):1189-92. PubMed ID: 4213193
    [No Abstract]   [Full Text] [Related]  

  • 14. Dibutyryl cyclic AMP, adenosine and guanosine blockade of the dopamine, ergocryptine and apomorphine inhibition of prolactin release in vitro.
    Hill MK; Macleod RM; Orcutt P
    Endocrinology; 1976 Dec; 99(6):1612-7. PubMed ID: 187415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of the serotonergic and dopaminergic systems on prolactin secretion in the rat. The mechanism of action of the "specific" serotonin receptor antagonist, methysergide.
    Lamberts SW; MacLeod RM
    Endocrinology; 1978 Jul; 103(1):287-95. PubMed ID: 744080
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inhibition of prolactin secretion by ergocornine and 2-Br-alpha-ergocryptine: direct action on the hypophysis in culture].
    Pasteels JL; Danguy A; Frérotte M; Ectors F
    Ann Endocrinol (Paris); 1971; 32(1):188-92. PubMed ID: 5556257
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopaminergic stimulation of prolactin release.
    Denef C; Manet D; Dewals R
    Nature; 1980 May; 285(5762):243-6. PubMed ID: 6154895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resumption of prolactin secretion after dopaminergic inhibition: differential effects of dopamine and its agonists.
    Woolf PD
    Am J Physiol; 1981 Jun; 240(6):E700-4. PubMed ID: 7246736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bovine serum prolactin, growth hormone, cortisol and milk yield after ergocryptine.
    Smith VG; Beck TW; Convey EM; Tucker HA
    Neuroendocrinology; 1974; 15(3-4):172-81. PubMed ID: 4472947
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolactin and growth hormone production as influenced by catecholamines and agents that affect brain catecholamines.
    MacLeod RM; Fontham EH; Lehmeyer JE
    Neuroendocrinology; 1970; 6(5):283-94. PubMed ID: 5482108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.